Review the Clarity Cream source preparation, its listed specifications and the details your practice should confirm with the pharmacy.
For product identification and informed clinic review. No patient checkout is provided.
Emerald names Clarity Cream with 10/4/2/0.1% and lists 30 g / 60 g / 90 g. It does not identify the ingredients or explicitly assign a percentage to a component. Confirm the selected package and full formulation.
Listed package: 30 g / 60 g / 90 g — source package options. Confirm the complete formulation, ingredient identities, percentage basis, dosage form, labeling and current pharmacy requirements. Source specifications are not application or dosing instructions.
Explore source listing1 source entry. Open the pharmacy to review its listings and confirmation notes.
| Source preparation / review note | Listed amount / specification | Package |
|---|---|---|
| clarity cream 10/4/2/0.1%Ingredient identities and percentage mapping are missing. Confirm the complete cream formulation and selected package. | 10 / 4 / 2 / 0.1% — unassigned source sequence | 30 g / 60 g / 90 g — source package options |
Review the exact product with the responsible pharmacy before submitting an order.
Check the ingredient name and its complete specification.
Review product-specific evidence and regulatory information.
Confirm missing or conflicting fields with the pharmacy.
Any further action depends on the exact product and applicable requirements.
CoreLink does not prescribe or dispense. Reference listings are not offers to supply products.
The treating clinician determines suitability and prescribing. Review the exact preparation’s labeling and pharmacy information.
Clarity is a catalog name, not an established ingredient formula or a skin outcome. Do not infer ingredients from similarly named products.
FDA explains that compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness or quality before marketing. The source name does not validate this unidentified cream formula. FDA: understanding compounded-drug risks
Compounded drugs are not FDA-approved and do not undergo FDA premarket review for safety, effectiveness or quality. FDA: compounded drug information
Sources checked October 19, 2026. This page provides product information, not diagnosis, treatment selection, dosing or administration instructions.
The catalog does not supply ingredient identities or percentage mapping. Obtain a full ingredient-by-ingredient specification and percentage basis from Emerald; no customary formula is assumed.
No. A source entry does not establish approval, safety, effectiveness, current availability or eligibility. Review the exact preparation and current requirements with the responsible pharmacy.
No. Ingredient concentration, total content and package volume are separate specifications. This page gives no dosing, preparation or administration instructions.
No. Verify the exact product and its regulatory status. A compounded preparation is not FDA-approved, and a reference to an approved product does not establish equivalence.
A shared ingredient name or numerical value does not establish equivalence. Confirm the complete ingredient form, formulation, route and product labeling.
Ask for the exact ingredient identity, full formulation, strength units, dosage form, route, package, current labeling and applicable requirements. Resolve missing or conflicting information.
No. These pages provide reference information and no patient checkout. Patients should discuss treatment with their treating clinician.
Email info@corelinkpharm.com for platform questions. Contact the responsible pharmacy for preparation-specific information.
Contact CoreLink for account information. Ask the pharmacy about exact product specifications and eligibility.